AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Compass Therapeutics, Inc. Director's Dealing 2022

Apr 28, 2022

32588_dirs_2022-04-28_d12650cc-1fa6-4d59-9046-78830d26c485.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Compass Therapeutics, Inc. (CMPX)
CIK: 0001738021
Period of Report: 2022-04-26

Reporting Person: Chiniara Ellen (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $.0001 Par Value	0	Direct